Search
Search Results
##search.searchResults.foundPlural##
-
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1911PDF: 950HTML: 1570 -
Is laboratory monitoring useful in DOACs management?
956PDF: 882HTML: 135 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1671PDF: 975HTML: 397 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3623PDF: 1472HTML: 2740 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1793PDF: 572MP4: 486Html: 318 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4477PDF: 1461HTML: 2209 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3167PDF: 1099HTML: 3342 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4453PDF: 1614HTML: 482 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1472PDF: 649Suppl. Files: 397HTML: 184 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3082PDF: 1094HTML: 5668 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4688PDF: 1570HTML: 8554 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4964PDF: 1634HTML: 2279Untitled: 278Untitled: 298Untitled: 315Untitled: 268Untitled: 281 -
RECENT ADVANCES IN THE 5Q- SYNDROME
3143PDF: 1941HTML: 3842Pellagatti Fig 1: 270Pellagatti Fig. 2: 256 -
-
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3902PDF: 1375HTML: 2190Fig.1: 285Fig. 2: 264 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1445PDF: 812HTML: 424 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1915PDF: 653HTML: 370 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4223PDF: 1239HTML: 2122Fig.1: 249Fig. 2: 142Table 1: 254Table2: 275Table 3: 260 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3531PDF: 1603HTML: 4090 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7966PDF: 2529HTML: 2166Table 1.: 277Table 2.: 290Table 3.: 267Table 4.: 263 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2616HTML: 358PDF: 973 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4791PDF: 2055HTML: 18225 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3275PDF: 959HTML: 7320Kost Fig1: 233Kost Fig 2: 220Kost Fig3: 234Kost Fig 4: 245Kost Fig5: 243Kost fig 6: 230 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
2314PDF: 658HTML: 1181 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2334PDF: 1717HTML: 747 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5549PDF: 1423HTML: 2890Cover letter: 250 -
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2503PDF: 1081HTML: 1674Fig 1: 261Tab I: 262Cover Letter: 268 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1751PDF: 889HTML: 1287Figure 1: 218Figure 2: 230Figure 3: 230







